Results 171 to 180 of about 20,704 (180)

α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis

Clinical and Experimental Immunology, 2010
Chun-Ying Wu, Guan-Jie Chen
exaly  

Protective Role for Interferon-β in Coxsackievirus B3 Infection

Circulation, 2004
Eleanor N Fish
exaly  

Atypical hand-foot-and-mouth disease associated with coxsackievirus A6 infection

Journal of the American Academy of Dermatology, 2013
Jason P Lott, W Allan Nix, M Steven Oberste   +2 more
exaly  

Autoimmunity in coxsackievirus B3 induced myocarditis

Autoimmunity, 2006
Sally A Huber
exaly  

Coxsackievirus Group B Infections during Pregnancy: An Updated Literature Review

Journal of Clinical Medicine
Heron Werner, Julio Élito, Edward Araujo Júnior   +2 more
exaly  

Detection of coxsackievirus A10 in multiple tissues of a fatal infant sepsis case

Journal of Clinical Virology, 2012
Daryl M Lamson, Kirsten St George
exaly  

Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor

Gene Therapy, 2007
H-P Schultheiss, Henry Fechner, Wolfgang Poller   +2 more
exaly  

[Diagnosis of coxsackievirus infection].

Nihon rinsho. Japanese journal of clinical medicine, 1990
openaire   +1 more source

Coxsackievirus B infections in adults.

Texas medicine, 1977
A W, McCracken, G J, Race
openaire   +1 more source

Animal Models for Coxsackievirus Infections

1999
openaire   +1 more source